Do We Need to Optimize Plasma Protein and Tissue Binding in Drug Discovery?

E-ISSN： 1873-4294|11|4|450-466

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.11, Iss.4, 2011-02, pp. : 450-466

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Why Do We Need New Drug Classes for HIV Treatment and Prevention?

Current Topics in Medicinal Chemistry, Vol. 16, Iss. 12, 2016-03 ,pp. : 1343-1349

Bentham Science Publishers

Access to resources Recommend Favorite

Transporter pharmacogenetics: do we need function? Do we need motion?

By Pastor-Anglada Marçal

Pharmacogenomics, Vol. 14, Iss. 13, 2013-10 ,pp. : 1537-1540

Future Medicine

Access to resources Recommend Favorite

Calculation of Normalized Drug Concentrations in the Presence of Altered Plasma Protein Binding

By >

Clinical Pharmacokinetics, Vol. 51, Iss. 1, 2012-01 ,pp. : 55-68

Adis International

Access to resources Recommend Favorite

The Assessment and Characterisation of Drug Plasma Protein Binding in the Body Using QSAR

Mini Reviews in Medicinal Chemistry, Vol. 14, Iss. 6, 2014-05 ,pp. : 484-493

Bentham Science Publishers

Access to resources Recommend Favorite

How Much Gets there and What Does it Do?: The Need for Better Pharmacokinetic and Pharmacodynamic Endpoints in Contemporary Drug Discovery and Development

Current Pharmaceutical Design, Vol. 9, Iss. 11, 2003-04 ,pp. : 891-902

Bentham Science Publishers

Access to resources Recommend Favorite